Dabrafenib is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma. Molecular Formula: C24H24F3N5O5S3 Solubility: DMSO (Slightly), Methanol (Slightly) Molecular Weight: 615.66999999999996 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
615.67
Form:
Supplied as a White Solid
CAS Number:
[1195768-06-9]
* VAT and and shipping costs not included. Errors and price changes excepted